Photodynamic application in neurosurgery: present and future

Photodynamic techniques such as photodynamic diagnosis (PDD), fluorescence guided tumor resection (FGR) and photodynamic therapy (PDT) are currently undergoing intensive clinical investigations as adjunctive treatment for malignant brain tumours. This review provides an overview on the current clinical data and trials as well as on photosensitisers, technical developments and indications for photodynamic application in Neurosurgery. Furthermore new developments and clinical significance of FGR for neurosurgery will be discussed. Over 1000 patients were enrolled in various clinical phase I/II trials for PDT for malignant brain tumours. Despite various treatment protocols, variation of photosensitisers and light dose there is a clear trend towards prolonging median survival after one single PDT as compared to conventional therapeutic modalities. The median survival after PDT for primary glioblastoma multiforme WHO IV was 19 months and for recurrent GBM 9 months as compared to standard convential treatment which is 15 months and 3 months, respectively. FGR in combination with adjunctive radiation was significantly superior to standard surgical resection followed by radiation. The combination of FGR/PDD and intraoperative PDT increased significantly survival in recurrent glioblastoma patients. The combination of PDD/ FGR and PDT offers an exciting approach to the treatment of malignant brain tumours "to see and to treat." PDT was generally well tolerated and side effects consisted of occasionally increased intracranial pressure and prolonged skin sensitivity against direct sunlight. This review covers the current available data and draws the future potential of PDD and PDT for its application in neurosurgery.

[1]  Andreas Obermeier,et al.  Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5‐aminolevulinic acid induced protoporphyrin IX , 2007, Lasers in surgery and medicine.

[2]  M. Ritsch-Marte,et al.  mTHPC-mediated Photodynamic Diagnosis of Malignant Brain Tumors¶ , 2001, Photochemistry and photobiology.

[3]  Herwig Kostron,et al.  mTHPC-mediated photodynamic detection for fluorescence-guided resection of brain tumors , 1998, Photonics West - Biomedical Optics.

[4]  H. Kostron,et al.  Combination of FOSCAN® mediated fluorescence guided resection and photodynamic treatment as new therapeutic concept for malignant brain tumors , 2006 .

[5]  Brian C Wilson,et al.  Photodynamic therapy of brain tumors—A work in progress , 2006, Lasers in surgery and medicine.

[6]  T. Mang.  Dosimetric concepts for PDT. , 2008, Photodiagnosis and photodynamic therapy.

[7]  S. Stylli,et al.  Photodynamic therapy of cerebral glioma – A review Part II – Clinical studies , 2006, Journal of Clinical Neuroscience.

[8]  Theresa M Busch,et al.  Fluence rate as a modulator of PDT mechanisms , 2006, Lasers in surgery and medicine.

[9]  C. Gomer,et al.  Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response. , 2007, Cancer research.

[10]  M. Eljamel,et al.  Brain photodiagnosis (PD), fluorescence guided resection (FGR) and photodynamic therapy (PDT): past, present and future. , 2008, Photodiagnosis and photodynamic therapy.

[11]  Gabriele Schackert,et al.  Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. , 2008, Neuro-oncology.

[12]  S. Kaneko.  A Current Overview : Photodynamic Diagnosis and Photodynamic Therapy using 5-Aminolevulinic Acid in Neurosurgery , 2008 .

[13]  K. Jain,et al.  Use of nanoparticles for drug delivery in glioblastoma multiforme , 2007, Expert review of neurotherapeutics.

[14]  Henry Hirschberg,et al.  Influence of light fluence rate on the effects of photodynamic therapy in an orthotopic rat glioma model. , 2006, Journal of neurosurgery.

[15]  S. Thomson,et al.  Effect of photodynamic therapy on recurrent pituitary adenomas: clinical phase I/II trial ‘ an early report , 2000, British journal of neurosurgery.

[16]  Z L Gokaslan,et al.  A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. , 2001, Journal of neurosurgery.

[17]  Paul Baas,et al.  Photodynamic therapy in oncology. , 2006, The oncologist.

[18]  N. Robillard,et al.  Influence of epidermal growth factor on photodynamic therapy of glioblastoma cells in vitro , 1997, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

[19]  Henry Hirschberg,et al.  Repetitive photodynamic therapy of malignant brain tumors. , 2006, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[20]  Q. Peng,et al.  Photochemical Internalization of Bleomycin is Superior to Photodynamic Therapy Due to the Therapeutic Effect in the Tumor Periphery , 2009, Photochemistry and photobiology.

[21]  Stefan Andersson-Engels,et al.  Clinical system for interstitial photodynamic therapy with combined on-line dosimetry measurements. , 2005, Applied optics.

[22]  L. Lilge,et al.  Fluorescence image-guided brain tumour resection with adjuvant metronomic photodynamic therapy: pre-clinical model and technology development , 2005, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[23]  Britton Chance,et al.  A novel approach to a bifunctional photosensitizer for tumor imaging and phototherapy. , 2005, Bioconjugate chemistry.

[24]  M. Sam Eljamel,et al.  ALA and Photofrin® Fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trial , 2008, Lasers in Medical Science.

[25]  Mukund Seshadri,et al.  Light Delivery over Extended Time Periods Enhances the Effectiveness of Photodynamic Therapy , 2008, Clinical Cancer Research.

[26]  Tayyaba Hasan,et al.  Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy. , 2005, International journal of radiation oncology, biology, physics.